Boston Scientific Announces Positive Long-Term Outcomes For S-ICD System In The EFFORTLESS Study

Boston Scientific (NYSE:BSX) today announced results from the largest post-market registry for the Subcutaneous Implantable Defibrillator (S-ICD) System.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news
More News: Medical Devices | Study